Olszewski W L
Department of Surgical Research and Transplantology, Medical Research Center, Polish Academy of Sciences, Warsaw, Poland.
Int Angiol. 2011 Dec;30(6):499-503.
The microsurgical lympho-venous shunts have become one of the generally accepted modalities in treatment of limb lymphedema. This review highlight the indications for this procedure after over 40 years. This study was based on the personal experience of one surgeon and on the review of the literature. Patients with postinflammatory, postsurgical, idiopathic and hyperplastic lymphedema of lower limbs were included in the study. Basing on the review of results of the last 40 years the contemporary indications are: 1) lymphedema with local segmental obstruction but still partly patent distal lymphatics seen on functional lymphoscintigraphy (standard walking or pneumatic compression) and without an active inflammatory process in the skin, subcutaneous tissue and lymph vessels (DLA-dermatolymphangioadenitis); 2) classified according the etiology of lymphedema, this operation can bring about satisfactory results in cases of hyperplastic, postsurgical and postinflammatory types of lymphedema, whereas primary idiopathic lymphedema of non-genetic type should be treated with conservative means, although in a small number of cases an improvement was observed after lympho-venous shunting as long as 10 years. Microsurgical lymph node or lymphatic vessel to vein shunts have their established position among the therapy modalities for lymphedema of lower limbs in a strictly defined group of patients using lymphoscintigraphic imaging.
显微外科淋巴静脉分流术已成为治疗肢体淋巴水肿普遍接受的方法之一。这篇综述着重介绍了40多年来该手术的适应证。本研究基于一位外科医生的个人经验及文献回顾。研究纳入了患有炎症后、术后、特发性和增生性下肢淋巴水肿的患者。基于对过去40年结果的回顾,目前的适应证为:1)功能性淋巴闪烁显像(标准行走或气压压迫)显示淋巴水肿伴有局部节段性梗阻,但远端淋巴管仍部分通畅,且皮肤、皮下组织和淋巴管无活动性炎症过程(DLA - 皮肤淋巴管腺炎);2)根据淋巴水肿的病因分类,该手术在增生性、术后和炎症后类型的淋巴水肿病例中可取得满意效果,而非遗传性原发性特发性淋巴水肿应以保守方法治疗,不过少数病例在淋巴静脉分流术后长达10年仍观察到病情改善。在使用淋巴闪烁显像的严格定义患者组中,显微外科淋巴结或淋巴管与静脉分流术在下肢淋巴水肿的治疗方式中占有一席之地。